Testing the AVI-7100 Flu Drug in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 8, 2012

Primary Completion Date

June 29, 2016

Study Completion Date

June 29, 2016

Conditions
Influenza
Interventions
DRUG

AVI-7100 versus placebo

dose-escalating AVI-7100 versus placebo

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01747148 - Testing the AVI-7100 Flu Drug in Healthy Volunteers | Biotech Hunter | Biotech Hunter